Ketanserin
Systematic (IUPAC) name | |
---|---|
3-{2-[4-(4-fluorobenzoyl)piperidin-1-yl]ethyl}quinazoline-2,4(1H,3H)-dione
|
|
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Identifiers | |
CAS Number | 74050-98-9 |
ATC code | C02KD01 (WHO) QD03AX90 (WHO) |
PubChem | CID: 3822 |
IUPHAR/BPS | 88 |
ChemSpider | 3690 |
UNII | 97F9DE4CT4 |
KEGG | D02363 |
ChEBI | CHEBI:6123 |
ChEMBL | CHEMBL51 |
Chemical data | |
Formula | C22H22FN3O3 |
Molecular mass | 395.43 g/mol |
|
|
|
|
(what is this?) (verify) |
Ketanserin (INN, USAN, BAN) (brand name Sufrexal; former code name R41468) is a drug used clinically as an antihypertensive agent and in scientific research to study the serotonin system; specifically, the 5-HT2A receptor.[1] It was discovered at Janssen Pharmaceutica in 1980.
Contents
Uses
Antihypertensive
It is classified as an antihypertensive by the World Health Organization[2] and the National Institute of Health.[3]
It has been used to reverse pulmonary hypertension caused by protamine (which in turn was administered to reverse the effects of heparin overdose).[4]
The reduction in hypertension is not associated with reflex tachycardia.[5]
It has been used in cardiac surgery.[6]
As a radioligand
With tritium (3H) radioactively labeled ketanserin is used as a radioligand for the serotonin 5-HT2A receptor, e.g. in receptor binding assays and autoradiography.[7] This radiolabeling enables the study of the serotonin-2A receptor distribution in the human brain.[8]
An autoradiography study of the human cerebellum has found an increasing binding of H-3-ketanserin with age (from below 50 femtomol per milligram tissue at around 30 years og age to over 100 above 75 years).[9] The same research team found no significant correlation with age in their homogenate binding study.
As a blocker with another radioligand
Ketanserin has also been used with carbon (11C) radioactively labeled NNC112 in order to image cortical D1 receptors without contamination by 5-HT2A receptors.[10]
Pharmacology
Ketanserin is a high-affinity antagonist of the 5-HT2A receptor (Ki = 2-3 nM).[11][12] However, it also blocks the H1 receptor with high affinity (Ki = 2 nM).[12][13] In addition, ketanserin less potently antagonizes the α1-adrenergic (Ki = ~40 nM),[13] α2-adrenergic = ~200 nM), 5-HT1D (Ki = ? nM),[11][14] 5-HT2B (Ki = ? nM),[15] 5-HT2C (Ki = 100 nM),[13] 5-HT6 (Ki = ~300 nM),[16] 5-HT7 (Ki = ? nM),[11] D1 (~300 nM),[13] and D2 (Ki = ~500 nM) receptors.[12][13] It also blocks the vesicular monoamine transporter (VMAT2).[17][18]
See also
References
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ ATC/DDD Index
- ↑ Ketanserin
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ 11.0 11.1 11.2 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ 12.0 12.1 12.2 NIMH Psychoactive Drug Screening Program
- ↑ 13.0 13.1 13.2 13.3 13.4 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- Chemical articles having calculated molecular weight overwritten
- Infobox drug articles without a structure image
- Chemical pages without DrugBank identifier
- Drugs with no legal status
- Alpha-1 blockers
- Alpha-2 blockers
- 5-HT1D antagonists
- 5-HT2A antagonists
- 5-HT2C antagonists
- 5-HT6 antagonists
- 5-HT7 antagonists
- D1 antagonists
- D2 antagonists
- H1 receptor antagonists
- Antihypertensive agents
- Organofluorides
- Ketones
- Piperidines
- Quinazolines
- Lactams
- Ureas
- Imides
- Janssen Pharmaceutica
- VMAT inhibitors
- Abandoned drugs